Wildcat Venture Partners
Phyllis Whiteley, PhD., is a Venture Capitalist and a Life Sciences consultant. She is currently a Venture Partner with Wildcat Venture Partners where she provides hands-on leadership in building, investing, and creating companies in the digital health space. She is also a Venture Partner with Mohr Davidow Ventures where she focused on diagnostics, life science tools, digital health, and personalized medicine including Verinata Health, acquired by Illumina (NASDAQ: ILMN). Phyllis’ career is grounded on her passion for personalized medicine, global healthcare, and transformative life science innovations. She has founded and built multiple companies in the United States and abroad. She is on the Board of Carrum Health and Balance Therapeutics.
Her executive expertise includes strategic planning, R&D, start-ups, M&A, restructuring, and building executive teams. Prior to joining WVP and MDV, Phyllis was an EIR with 5am Ventures where she co-founded Anaphore (now Bird Rock Bio). Prior to VC, Phyllis was an Officer and SVP, Business Development, Licensing, and Alliance Management at Perlegen Sciences, Inc. Before Perlegen, she served as VP, Strategic Portfolio Management for Roche. Over her ten-year career with Roche she held various positions in Business Development based in Basel, Switzerland coupled with R&D leadership positions in the US. Phyllis also held a Senior Research Immunology role with Merck.
Phyllis is dedicated to helping entrepreneurs address global problems. She sits on the advisory boards of UCSF Leadership Council for Global Health, University of Michigan School of Nursing Board for Science and Innovation, is a Global Social Benefits Mentor at Santa Clara University and chairs the advisory board for the University of Texas Horizon Fund. Phyllis also serves on the board of Alydia Health, a medical device company treating Post-Partum Hemorrhage.
Phyllis holds a BA in Chemistry and Ph.D. in Pharmacology from Washington University, St. Louis, Missouri.
Tuesday, January 28, 2020
2:30 PM – 3:45 PM